Serum and tissue ldh levels in patients with breast/gynaecological cancer and benign diseases

Gynecologic and Obstetric Investigation

Volumn 67, Issue 3, 2009, Pages 162-168

  Koukourakis, Michael I ^a   Kontomanolis, Emmanuel ^a   Giatromanolaki, Alexandra ^a   Sivridis, Efthimios ^a   Liberis, Vassilios ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Breast cancer; Endometrial cancer; Lactate dehydrogenase; Ovarian cancer

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; LACTATE DEHYDROGENASE;

ARTICLE; BENIGN TUMOR; BREAST CANCER; BREAST FIBROADENOMA; CANCER CELL; CONTROLLED STUDY; CYSTADENOCARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; GYNECOLOGIC CANCER; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY ADENOCARCINOMA; OVARY CYST; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERUS MYOMA;

ADENOCARCINOMA; ADULT; BREAST NEOPLASMS; CYSTADENOMA; FEMALE; FIBROADENOMA; GENITAL NEOPLASMS, FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISOENZYMES; L-LACTATE DEHYDROGENASE; LEIOMYOMA; UP-REGULATION;

EID: 57649086035     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000183250     Document Type: Article

References (22)

1. Holbrook JJ, Liljas A, Steindel SJ, Rossman MG: Lactate dehydrogenase; in Boyer PD (ed): The Enzymes, 3rd ed. New York, Academic Press, 1975, vol XI, pp 191-292.
2. Harris AL: Hypoxia: a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38-47.
3. Elstrom RL, Bauer DE, Buzzai M, et al: Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 2004; 64: 3892-3899.
4. Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL: HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1 - (HIF-1 -) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 2001; 21: 3995-4004.
5. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, Giallongo A: Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 1996; 271: 32529-32537.
6. Warburg O: The Metabolism of Tumors. New York, R.R. Smith Inc, 1931.
7. Halestrap AP, Price NT: The proton-linked monocarboxylate transporter family: structure, function and regulation. Biochem J 1999; 2: 281-299.
8. Rozhin J, Sameni M, Ziegler G, Sloane BF: Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res 1994; 54: 6517-6525.
9. Martinez-Zaguilan R, Seftor EA, Seftor RE, Chu YW, Gillies RJ, Hendrix MJ: Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metastasis 1996; 14: 176-186.
10. Zabel DD, Feng JJ, Scheuenstuhl H, Hunt TK, Hussain MZ: Lactate stimulation of macrophage-derived angiogenic activity is associated with inhibition of poly(ADP-ribose) synthesis. Lab Invest 1996; 74: 644- 649.
11. Stubbs M, McSheehy PM, Griffiths JR, Bashford CL: Causes and consequences of tumour acidity and implications for treatment. Mol Med Today 2000; 6: 15-19.
12. Argiris A, Murren JR: Staging and clinical prognostic factors for small-cell lung cancer. Cancer J 2001; 7: 437-447.
13. Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, Dewhirst MW, Mueller- Klieser W: Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 51: 349-353.
14. Kemeny N, Niedzwiecki D, Shurgot B, Oderman P: Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement. Cancer 1989; 63: 742-747.
15. Koukourakis MI, Giatromanolaki A, Sivridis E: Lactate dehydrogenase isoenzymes 1 and 5: differential expression by neoplastic and stromal cells in non-small cell lung cancer and other epithelial malignant tumors. Tumour Biol 2003; 24: 199-202.
16. Sorensen BS, Hao J, Overgaard J, Vorum H, Honore B, Alsner J, Horsman MR: Influence of oxygen concentration and pH on expression of hypoxia induced genes. Radiother Oncol 2005; 76: 187-193.
17. Greijer AE, van der Groep P, Kemming D, Shvarts A, Semenza GL, Meijer GA, van de Wiel MA, Belien JA, van Diest PJ, van der Wall E: Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia- inducible factor 1. J Pathol 2005; 206: 291-304.
18. Amador E, Dorfman LE, Wacker WEC: Serum lactic dehydrogenase activity: an analytical assessment of current assays. Clin Chem 1963; 9: 391-399.
19. Sivridis E, Giatromanolaki A, Gatter KC, Harris AL, Koukourakis MI, Tumor and Angiogenesis Research Group: Association of hypoxia-inducible factors 1 - and 2 - with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Cancer 2002; 95: 1055-1063.
20. Giatromanolaki A, Sivridis E, Gatter KC, Turley H, Harris AL, Koukourakis MI, for the Tumour and Angiogenesis Research Group: Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis. Gynecol Oncol 2006; 103: 912-918.
21. Koukourakis MI, Giatromanolaki A, Sivridis E, Bougioukas G, Didilis V, Gatter KC, Harris AL, Tumour and Angiogenesis Research Group: Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer 2003; 89: 877- 885.
22. Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL, Tumour Angiogenesis Research Group: Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway - a report of the Tumour Angiogenesis Research Group. J Clin Oncol 2006; 24: 4301-4308.